Transcriptomic analysis of castration, chemo-resistant and metastatic prostate cancer elucidates complex genetic crosstalk leading to disease progression-Reference-Cited by-同舟云学术

Transcriptomic analysis of castration, chemo-resistant and metastatic prostate cancer elucidates complex genetic crosstalk leading to disease progression

Published:2021-06-29 Issue:3-4 Volume:21 Page:451-472
ISSN:1438-793X
Container-title:Functional & Integrative Genomics
language:en
Short-container-title:Funct Integr Genomics

Author:

Mukherjee Sayani,Sudandiradoss C.

Publisher

Springer Science and Business Media LLC

Subject

Genetics,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10142-021-00789-6.pdf

Reference101 articles.

1. Jianzhong Ai, Tao Jin, Lu Yang, Qiang Wei, Yang Yang, Hong Li (2017) Vinculin and filamin-C are two potential prognostic biomarkers and therapeutic targets for prostate cancer cell migration. Oncotarget 8(47):82430–36

2. Barakat DJ, Zhang J, Barberi T, Denmeade SR, Friedman AD (2015) CCAAT/enhancer binding protein β controls androgen- deprivation-induced senescence in prostate cancer cells. Oncogene 34(48):5912–22. https://doi.org/10.1038/onc.2015.41

3. Omer B, Shpringer R, Argov CM, Lotem EY (2018) The DifferentialNet database of differential protein–protein interactions in human tissues. Nucleic Acids Res 46(D1):522–26. https://doi.org/10.1093/nar/gkx981

4. Baygi ME, Soheili ZS, Essmann F, Deezagi A, Engers R, Goering W, Schulz WA (2010) Slug/SNAI2 regulates cell proliferation and invasiveness of metastatic prostate cancer cell lines. Tumour Biol 31(4):297–307. https://doi.org/10.1007/s13277-010-0037-5

5. Bednarek, Andrzej K. 2017. Markers of epithelial-to-mesenchymal transition reflect tumor biology according to patient age and Gleason score in prostate cancer, 1–23.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SVIL promotes ovarian cancer progression and epithelial-mesenchymal transition under hypoxic conditions through the TGF-β/Smad pathway;Gynecologic Oncology;2024-11

2. LncRNA CTBP1‐AS inhibits TP63‐mediated activation of S100A14 during prostate cancer progression;Cancer Science;2024-03-13

3. HNRNPA2B1-mediated m6A modification of FOXM1 promotes drug resistance and inhibits ferroptosis in endometrial cancer via regulation of LCN2;Functional & Integrative Genomics;2023-12-13

4. Duality of the SVIL expression in bladder cancer and its correlation with immune infiltration;Scientific Reports;2023-09-05

5. Hyper-methylation of ABCG1 as an epigenetics biomarker in non-small cell lung cancer;Functional & Integrative Genomics;2023-07-31